Search results
AstraZeneca invests in Nucleus RadioPharmaceuticals - Minneapolis / St. Paul Business Journal
The Business Journals· 2 days agoAfter completing a $56 million Series A funding round in 2023, Nucleus RadioPharma scored an...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 2 days agoThe American Society of Clinical Oncology held its annual conference in Chicago this past week,...
3 No-Brainer Stocks to Buy in June | The Motley Fool
The Motley Fool· 6 days agoYou're probably familiar with the old adage, "April showers bring May flowers." Here's why they picked AbbVie (ABBV 3.15%), AstraZeneca (AZN 1.63%), and...
AstraZeneca immunotherapy extends survival by two years in rarer type of lung cancer
BioPharma Dive via Yahoo Finance· 6 days agoAstraZeneca’s immunotherapy Imfinzi helped people in the early stages of a type of lung cancer live...
AstraZeneca Gets Workers’ Covid-19 Faith Bias Suit Narrowed
Bloomberg Law· 2 days ago‘s bid to dismiss some claims from workers who asserted religious objections to its Covid-19 vaccination mandate proved successful when a federal court adopted a magistrate judge’s recommendations ...
With new Enhertu data, an ADC could overtake chemo in breast cancer
BioPharma Dive via Yahoo Finance· 6 days agoStudy participants had already received one hormone therapy and a type of drug called a CDK 4/6...
Patient’s Dark Fantasy About Aetna Lands Him in Jail
The Daily Beast via Yahoo News· 4 days agoMany Americans loathe their health insurance providers.A majority say they have severe concerns about financial hardship due to medical bills—even with...
Council Post: 18 Reasons Why Sustainability Can Be A Strategic Business Advantage
Forbes· 1 day agoIn recent years, sustainability has become a key topic amongst individuals and businesses. As the public becomes increasingly aware of climate change and their role in reducing unnecessary waste ...
AstraZeneca’s breast cancer trial shows ‘unprecedented’ results | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 6 days agoAstraZeneca and Daiichi Sankyo’s Enhertu slows the progression of breast cancer by about five months...
Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support...
Morningstar· 7 days agoTempus, a leader in artificial intelligence and precision medicine, today announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm ...